Projects Funded from April 2007
Location: European Institute of Oncology, Italy
Project Title: Role of p31comet in the regulation and adaptation of the spindle assembly checkpoint
Funds Awarded: £90,047
Location: Institute of Child Health, United Kingdom (England)
Project Title: Role of CD44 and Rho GTPase signalling in cancer cell extravasation
Funds Awarded: £161,790
Location: University of Crete, Greece
Project Title: Immunomodulation by tumour –derived neuropeptides; the role of CRF peptide family in cancer
Funds Awarded: £82,127
Location: Institute of Child Health, United Kingdom (England)
Project Title: Regulation of the Brn-3a transcription factor by genetic and environmental factors and its role in HPV-induced cervical cancer.
Funds Awarded: £169,406
Location: St. Vincent's Institute, Australia
Project Title: A new mouse model of myeloid leukaemia
Funds Awarded: £184,798
Location: Centre National de la Recherche Scientifique, France
Project Title: Characterization of HIC1 transcriptional targets
Funds Awarded: £99,488
Location: The FIRC Institute of Molecular Oncology Foundation, Italy
Project Title: The role of VE-cadherin and beta catenin in angiogenesis
Funds Awarded: £100,983
Location: University of Leicester, United Kingdom (England)
Project Title: Regulation and function of the AP-1 family member, Fos-
related antigen-1 (Fra-1) in cancer cells.
Funds Awarded: £157,442
Location: Institut Cochin, INSERM, France
Project Title: IEX-1: a new actor in the ERK and PP2A signaling pathways. Role in hematopoietic cells and involvement in acute myeloid leukemia
Funds Awarded: £72,984
Location: Erasmus Medical Center, Netherlands
Project Title: Wnt-Notch interactions in normal and malignant hematopoiesis
Funds Awarded: £185,463
Location: Erasmus University Rotterdam, Netherlands
Project Title: TFIIH stability and activities: contribution to carcinogenesis
Funds Awarded: £162,003
Location: Marie Curie Research Institute, United Kingdom (England)
Project Title: Identification and functional analysis of novel APC/C substrates and regulators
Funds Awarded: £156,401
Location: Institut Curie, France
Project Title: Involvement of the calcineurin/NFAT signaling pathway in lymphoma/leukemogenesis
Funds Awarded: £120,094
Location: University of Dundee, United Kingdom (Scotland)
Project Title: Design of Neh2 mini-proteins that inhibit Keap1 and elicit a cancer chemopreventive antioxidant response in the absence of redox stress
Funds Awarded: £158,113
Location: Umea University, Sweden
Project Title: Discovery of new targeted interventions of Myc-induced cancer
Funds Awarded: £132,620
Location: University of Glasgow, United Kingdom (Scotland)
Project Title: The role of the chromatin unfolding protein HMGN1 in the cellular response to DNA damage
Funds Awarded: £156,653
Location: MRC Laboratory of Molecular Biology, United Kingdom (England)
Project Title: The role of SUMO in DNA repair
Funds Awarded: £149,576
Location: University of Copenhagen, Copenhagen
Project Title: Functional role of the JMJD2 histone demethylases in cell proliferation and cancer
Funds Awarded: £164,177
Location: University Medical Center Utrecht, Netherlands
Project Title: Tumour immune evasion from cellular immunity: a new role for collagen
Funds Awarded: £150,192
Location: University of Sydney, Australia
Project Title: LMO4-DEAF-1 interactions in cellular development and breast cancer
Funds Awarded: £39,456
Location: Karolinska Institute, Sweden
Project Title: Regulation of tumor cell growth and homotypic adhesion by UCH-L1
Funds Awarded: £133,134
Location: The FIRC Institute of Molecular Oncology Foundation, Italy
Project Title: Analysis of the mechanism of tumor-antigen cross-presentation induced by Salmonella typhimurium
Funds Awarded: £102,945
Location: MRC Laboratory of Molecular Biology, United Kingdom (England)
Project Title: Proteins interacting with the APC tumour suppressor
Funds Awarded: £195,807
Location: Cleveland Clinic, Lerner Research Institute, United States
Project Title: Identifying a novel Wilms’ tumour suppressor gene at 2q37
Funds Awarded: £85,079
Location: Institute for Biomedical Research, Switzerland
Project Title: Role of PTP1B in Breast Cancer
Funds Awarded: £139,903
Location: Western General Hospital, United Kingdom (England)
Project Title: Is WT1 an oncogene?
Funds Awarded: £167,009
Location: The Hebrew University-Hadassah Medical School, Israel
Project Title: Tumour development in the absence of the NK activating
receptor NCR1
Funds Awarded: £117,519
Location: Kings College London, United Kingdom (England)
Project Title: Does the muscle satellite cell constitute a cellular source of alveolar rhabdomyosarcoma?
Funds Awarded: £173,940
Location: University of Texas Health Science Center, United States
Project Title: Role of PTPRD in Neuroblastoma Pathogenesis
Funds Awarded: £136,425
Location: Peter MacCallum Cancer Centre, Australia
Project Title: Identification of cell surface proteins that dictate site specific metastasis of breast cancer
Funds Awarded: £133,628
Location: University of Dundee, United Kingdom (Scotland)
Project Title: Regulation of IKK function following Hypoxia
Funds Awarded: £148,646
Location: VU University Medical Center, Netherlands
Project Title: Recognition of glycosylated tumor antigens by C-type lectins on DC to enhance anti-tumor responses
Funds Awarded: £166,969
Project Title: Role of p31comet in the regulation and adaptation of the spindle assembly checkpoint
Funds Awarded: £90,047
Location: Institute of Child Health, United Kingdom (England)
Project Title: Role of CD44 and Rho GTPase signalling in cancer cell extravasation
Funds Awarded: £161,790
Location: University of Crete, Greece
Project Title: Immunomodulation by tumour –derived neuropeptides; the role of CRF peptide family in cancer
Funds Awarded: £82,127
Location: Institute of Child Health, United Kingdom (England)
Project Title: Regulation of the Brn-3a transcription factor by genetic and environmental factors and its role in HPV-induced cervical cancer.
Funds Awarded: £169,406
Location: St. Vincent's Institute, Australia
Project Title: A new mouse model of myeloid leukaemia
Funds Awarded: £184,798
Location: Centre National de la Recherche Scientifique, France
Project Title: Characterization of HIC1 transcriptional targets
Funds Awarded: £99,488
Location: The FIRC Institute of Molecular Oncology Foundation, Italy
Project Title: The role of VE-cadherin and beta catenin in angiogenesis
Funds Awarded: £100,983
Location: University of Leicester, United Kingdom (England)
Project Title: Regulation and function of the AP-1 family member, Fos-
related antigen-1 (Fra-1) in cancer cells.
Funds Awarded: £157,442
Location: Institut Cochin, INSERM, France
Project Title: IEX-1: a new actor in the ERK and PP2A signaling pathways. Role in hematopoietic cells and involvement in acute myeloid leukemia
Funds Awarded: £72,984
Location: Erasmus Medical Center, Netherlands
Project Title: Wnt-Notch interactions in normal and malignant hematopoiesis
Funds Awarded: £185,463
Location: Erasmus University Rotterdam, Netherlands
Project Title: TFIIH stability and activities: contribution to carcinogenesis
Funds Awarded: £162,003
Location: Marie Curie Research Institute, United Kingdom (England)
Project Title: Identification and functional analysis of novel APC/C substrates and regulators
Funds Awarded: £156,401
Location: Institut Curie, France
Project Title: Involvement of the calcineurin/NFAT signaling pathway in lymphoma/leukemogenesis
Funds Awarded: £120,094
Location: University of Dundee, United Kingdom (Scotland)
Project Title: Design of Neh2 mini-proteins that inhibit Keap1 and elicit a cancer chemopreventive antioxidant response in the absence of redox stress
Funds Awarded: £158,113
Location: Umea University, Sweden
Project Title: Discovery of new targeted interventions of Myc-induced cancer
Funds Awarded: £132,620
Location: University of Glasgow, United Kingdom (Scotland)
Project Title: The role of the chromatin unfolding protein HMGN1 in the cellular response to DNA damage
Funds Awarded: £156,653
Location: MRC Laboratory of Molecular Biology, United Kingdom (England)
Project Title: The role of SUMO in DNA repair
Funds Awarded: £149,576
Location: University of Copenhagen, Copenhagen
Project Title: Functional role of the JMJD2 histone demethylases in cell proliferation and cancer
Funds Awarded: £164,177
Location: University Medical Center Utrecht, Netherlands
Project Title: Tumour immune evasion from cellular immunity: a new role for collagen
Funds Awarded: £150,192
Location: University of Sydney, Australia
Project Title: LMO4-DEAF-1 interactions in cellular development and breast cancer
Funds Awarded: £39,456
Location: Karolinska Institute, Sweden
Project Title: Regulation of tumor cell growth and homotypic adhesion by UCH-L1
Funds Awarded: £133,134
Location: The FIRC Institute of Molecular Oncology Foundation, Italy
Project Title: Analysis of the mechanism of tumor-antigen cross-presentation induced by Salmonella typhimurium
Funds Awarded: £102,945
Location: MRC Laboratory of Molecular Biology, United Kingdom (England)
Project Title: Proteins interacting with the APC tumour suppressor
Funds Awarded: £195,807
Location: Cleveland Clinic, Lerner Research Institute, United States
Project Title: Identifying a novel Wilms’ tumour suppressor gene at 2q37
Funds Awarded: £85,079
Location: Institute for Biomedical Research, Switzerland
Project Title: Role of PTP1B in Breast Cancer
Funds Awarded: £139,903
Location: Western General Hospital, United Kingdom (England)
Project Title: Is WT1 an oncogene?
Funds Awarded: £167,009
Location: The Hebrew University-Hadassah Medical School, Israel
Project Title: Tumour development in the absence of the NK activating
receptor NCR1
Funds Awarded: £117,519
Location: Kings College London, United Kingdom (England)
Project Title: Does the muscle satellite cell constitute a cellular source of alveolar rhabdomyosarcoma?
Funds Awarded: £173,940
Location: University of Texas Health Science Center, United States
Project Title: Role of PTPRD in Neuroblastoma Pathogenesis
Funds Awarded: £136,425
Location: Peter MacCallum Cancer Centre, Australia
Project Title: Identification of cell surface proteins that dictate site specific metastasis of breast cancer
Funds Awarded: £133,628
Location: University of Dundee, United Kingdom (Scotland)
Project Title: Regulation of IKK function following Hypoxia
Funds Awarded: £148,646
Location: VU University Medical Center, Netherlands
Project Title: Recognition of glycosylated tumor antigens by C-type lectins on DC to enhance anti-tumor responses
Funds Awarded: £166,969
